Scintigraphic Biomarkers for Colonic Dysmotility
- 21 April 2010
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 87 (6), 748-753
- https://doi.org/10.1038/clpt.2010.23
Abstract
Scintigraphic colonic transit measurement has emerged as a unique disease‐related biomarker pertinent to drug development and personalized therapy. This surrogate offers reproducible and accurate performance across a spectrum of common colonic motility disorders, linking colonic transit measurements to biological processes and clinical end points. The pathobiologic validity, prognostic utility, performance characteristics, evidence‐based linkage of therapeutic intervention with outcome, applicability across distinct pharmacodynamic profiles, and potential for individualizing patient management are all attributes of this gastrointestinal imaging paradigm. The cumulative evidence suggests that the integration of colonic transit measurement as a biomarker would accelerate the development and regulatory approval of therapeutic agents for the treatment of colonic dysmotility. Clinical Pharmacology & Therapeutics (2010) 87 6, 748–753. doi: 10.1038/clpt.2010.23Keywords
This publication has 35 references indexed in Scilit:
- Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functionsNeurogastroenterology & Motility, 2010
- Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohortNeurogastroenterology & Motility, 2010
- Effects of Velusetrag (TD‐5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipationNeurogastroenterology & Motility, 2009
- Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteersAlimentary Pharmacology & Therapeutics, 2009
- Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?American Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2008
- Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsClinical Gastroenterology and Hepatology, 2008
- Efficacy of On-Demand Asimadoline, a Peripheral κ-Opioid Agonist, in Females With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2007
- Efficacy and safety of bisacodyl in the acute treatment of constipation: a double‐blind, randomized, placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2006
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001